This is Dr. Sergio Giralt from Memorial Sloan-Kettering Cancer Center answering frequently asked questions regarding bendamustine.
I am frequently asked, “What are the side effects of bendamustine?” Bendamustine is currently available for the treatment of lymphoid malignancies, particularly chronic lymphocytic leukemia but it also can be used for multiple myeloma. It can only be administered intravenously and it is usually given over one or two days. It is associated with decreases in white count, platelet count, and red count. It may cause nausea, vomiting, weight loss, or diarrhea. It is important that bendamustine be administered under the supervision of an expert physician.
Reviewed on January 17, 2017 for clinical relevance.